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Bioshield 2: A Shot in the Right Direction?
By Lindsay Frank
Despite the introduction of the Biodefense and
Pandemic Vaccine & Drug Development Act of 2005
("Bioshield 2"),' pharmaceutical companies are still
reluctant to enter into the business of mass-producing
vaccines,2 and critics of the bill condemn the blanket
liability protections it provides to these companies.3
Introduced by Sen. Richard Burr (R-N.C.)
on October 17, 2005, Bioshield 2 was approved by a
voice-vote the next day by the Senate Health,
Education, Labor and Pensions Committee.' Bioshield
2 will allow drug companies to bypass typical testing
procedures for new vaccines and drugs in case of an
avian pandemic flu outbreak or bioterrorist attack.5
Moreover, Bioshield 2 aims to shield the
pharmaceutical companies who develop the vaccines
against personal injury lawsuits brought by individuals
suffering from adverse reactions or side effects caused
by the vaccine.6 The bill would offer 10-year market
exclusivity to drug companies, which would prevent
competitors from developing more affordable generic
alternatives.
This bill replaces the original Bioshield II
legislation that was designed by Sens. Joseph
Lieberman (D-Conn.) and Orrin Hatch (R-Utah).8
Bioshield II died because its "wild card" patent( 2x
kI I; V[1 I
Planning a national defense against bioterrorism and
pandemic disease has proved contentious among politicians,
pharmeccutical corporations, and public interest groups.
provision would have allowed pharmaceutical
companies developing bioterrorist countermeasures to
extend patents on their popular and exceedingly more
profitable drugs, even if those drugs were unrelated to
the production of countermeasures.9
For several years, the Bush Administration has
desired that pharmaceutical companies increase their
production of biodefense countermeasures with little
or no incentives.'o In fact, shortly after the anthrax
attacks in 2001, the Center for Disease Control
("CDC") asked Bayer Pharmaceutical, the makers of
Cipro, to get the FDA to approve the drug as a
treatment for anthrax." Bayer acted in accordance
with this request at their expense and further donated
four million doses of Cipro to the government.12
However, Bayer refused to comply with the
government's subsequent demand of an additional one
million doses at a discounted price, despite threats to
suspend their patent on Cipro.'I Recognizing the need
to provide pharmaceutical companies with greater
incentives, Project Bioshield was signed into law in
2004.14 The law provided the government with $5.6
billion over the next 10 years for the purchase of
vaccines and countermeasures designed to protect
Americans against anthrax, small pox and a chemical,
biological, radiological or nuclear ("CBRN") attack.
Despite the incentives to lure certain drug
makers into the biodefense and pandemic flu market,
very few of the large pharmaceutical companies jumped
at the opportunity to accept the grants offered by the
government.1 6 One reason for their skepticism was
the probable cost of approximately $800 million to $1
billion to develop a new drug without a guaranteed
market for it.'1 Additionally, the large pharmaceutical
companies did not avail themselves of the grant
because they were reluctant to divert research from
their popular and highly lucrative drugs to those that
are stockpiled and used in the event of an unlikely
emergency.'" The pharmaceutical industry was also
concerned with potential liability for administering
bioterror drugs that cannot first be tested on humans. 9
(Bioshield 2, continued on page 20)
Spring 200619 Public Interest Law Reporter
1
Frank: Bioshield 2: A Shot in the Right Direction?
Published by LAW eCommons, 2006
(Bioshield 2, continued from page 19)
In response to the lack of eagerness from larger
pharmaceutical companies, some of the smaller
pharmaceuticals companies have stepped up to the
challenge in order to obtain a government contract. 20
Yet, in some instances, their tremendous efforts and
equally high expectations have been met with
disappointing results. 2 1 For instance, Hollis-Eden
Pharmaceuticals, a small company located in San
Diego, experienced first hand what many other
companies had feared most.2 2 The company eagerly
pursued what would be its first government contract
and spent more than $100 million to develop Neumune,
a medicine designed to combat acute-radiation
sickness.23 Yet after the Department of Health and
Human Service's ("DHHS") initial request for bids,
Hollis-Eden learned that the government only planned
to buy 20,000 to 200,000 doses of their drug.24 This
number severely conflicted with what many industry
watchers believed would be a proposal for doses
numbering in the millions.2 5 While the DHHS
eventually stated that this was only a preliminary
number,26 it is not surprising that many companies have
shied away from the potentially devastating risks in
order to set their sights on more predictable and
profitable endeavors.2 7
Yet after increased fears of another biological
threat, avian flu, began to surface, the Bush
Administration pushed for measures to fix some of
Project Bioshield's highly criticized provisions? Due
to exceedingly high expenses and potential liability, the
major pharmaceutical players pressed the legislature
for more incentives to encourage entry into the
speculative market of bioterrorist and pandemic flu
countermeasures.29
Accordingly, Bioshield 2 was developed and
proposes to create a new federal agency called the
Biomedical Advanced Research and Development
Agency ("BARDA") that would promote and
coordinate "advanced research and development of
drugs and vaccines in response to bioterrorism and
natural disease outbreaks."3 0 Moreover, BARDA
would further streamline the approval process for
biodefense products and assist companies from the
early stages of product development until they are
ready to bid on a government contract.3 1 Currently,
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the Department of Homeland Security is responsible
for developing bioterrorism countermeasures. Under
Bioshield 2, BARDA would be protected from the
Federal Advisory Committee Act and the Freedom of
Information Act, which has sparked much controversy
over the bill.3 3 The Federal Advisory Committee Act
ensures that advice given to the executive branch" is
also given to the public, while the Freedom of
Information Act requires federal agencies to make their
records available to the public to the extent that they
are available.35 Instead, BARDA would be supervised
by a political appointee and proposes to allow the
research and development behind vaccines to be kept
secret from the public.36 Additionally, evidence of
deaths and injuries occurring from drugs and vaccines
labeled as "countermeasures" would also be kept
under wraps.37
"It's appalling that in the guise of a
health-related bill, the government is
giving the vaccine industry
unprecedented inununity for the harm
that their product can cause."
-Amber Hard, staff director for the Center for
Justice and Democracy
Bioshield 2 comes in wake of a $7.1 billion
strategy outlined in November 2005 by the Bush
Administration to expand and accelerate
pharmaceutical companies' capacity to produce
vaccines within the United States, stockpile treatments
against the H5N 1 avian influenza A virus, and detect
and respond to a pandemic flu outbreak.38 In addition,
Congress passed a defense bill last December that
included $3.8 billion, "mainly for flu vaccines and
medicines."39 The Bush Administration is hopeful that
the new legislation will appease the pharmaceutical
industry and enable companies to produce enough
vaccines for every American within six months of the
start of a pandemic outbreak."
Proponents of the bill argue that a liability
waiver is essential to avoid frivolous lawsuits, which
they attribute to hindering the progress of vaccine
(Bioshield 2, continued on page 21)
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(Bioshield 2, continued from page 20)
developments in recent decades. 41 They also assert
that a victim suffering from harmful side effects stemming
from a pandemic vaccine will not be left without a viable
remedy as the legislation plans to provide for a
compensation fund modeled after the Smallpox
Compensation Fund.4 2 The fund would allow injured
victims and their families to apply for death benefits,
lost income and medical expenses.4 3 In addition, the
DHHS has the right to waive the liability shield if a
pharmaceutical company is found to have willfully
neglected the risks associated with their product."
Critics of the legislation, including health, consumer
and union groups, 45 believe that pharmaceutical
companies' expressed fear of lawsuits is misplaced
and merely a way to avoid compensating injured
victims.4 6 In fact, only 10 lawsuits have been filed
against makers of influenza vaccines in the past 20
years.4 7 Additionally, despite the seeming lack of
enthusiasm from many pharmaceutical companies
towards Bioshield,4 8 the threat of lawsuits has not
inhibited some major manufactures of vaccines against
influenza such as Merck, Roche, Wyeth, Novartis and
GlaxoSmithKline from investing millions to increase
their stockpile.49 In particular, vaccine manufacturer
Santa Fe Pasteur has spent $150 million to double its
production capacity.50
Many Democrats opposed to the legislation
argue that Bioshield 2's liability protections are
detrimental to the public's best interest without a
sufficient compensation fund for those injured by the
vaccine.5 ' Although Republicans believe that a
compensation plan should be set up for "first
responders," many assert that it is nearly impossible
to set up a fund for those who take the drugs after a
bioterrorist attack, as compensation needs would be
contingent on the circumstances of each situation.52
This rather laissez faire approach to a compensation
policy is what worries critics who have compared the
lack of a tangible fund to the ultimate failure of the
Smallpox Vaccine and Compensation Act of 2003.53
The Act was designed to pursue the ultimate goal of
vaccinating approximately 500,000 public healthcare
workers against smallpox, but was unsuccessful largely
because of the government's failure to execute a
legitimate compensation plan.54 As a result, only
40,000 healthcare workers actually took part in the
vaccination program." Similarly, without a legitimate
compensation fund, critics of Bioshield 2 assert that
Americans will be largely hesitant to take these drugs
in the event of a biological attack or pandemic
outbreak.56
According to Amber Hard, staff director for
the Center for Justice and Democracy in Illinois, "[i]t's
appalling that in the guise of a health-related bill, the
government is giving the vaccine industry
unprecedented immunity for the harm that their product
can cause." 17 Hard went on to say that Bioshield 2
"makes all of us living guinea pigs and gives
pharmaceutical companies carte blanche to develop
drugs [that may not be safe for the general public].""
This is not the first time the government has
shielded pharmaceutical companies from liability against
lawsuits. Over the past 30 years, the government has
issued major liability protection and compensation
programs such as the National Swine Flu Immunization
Program of 1976,59 the National Childhood Vaccine
Injury Compensation Act of 198660 and the Phase I
Smallpox Vaccination Program that was launched in
2003.61 Yet the National Swine Flu Immunization
Program of 1976 did not limit the amount of
compensation recoverable by victims. 6 2 Rather, this
Act required injured victims to file their claims against
the government after filing an administrative claim. 63
The government was then able to "seek indemnification
from negligent parties covered by the liability
protections."" The National Childhood Vaccine Injury
Compensation Act of 1986 allowed injured plaintiffs
to go to court if they were not satisfied with the
administrative result and merely disallowed punitive
damages so long as the company had complied with
the Federal, Food, Drug and Cosmetic Act and the
Public Health ServiceAct.65 Finally, the more stringent
restrictions imposed by the smallpox vaccination
program proved catastrophic to the legislation as
people refused to subject themselves to the vaccine
without the possibility of adequate compensation.66
Similar to those opposed to the Smallpox
Vaccination Program, critics of Bioshield 2 argue that
the bill places too much emphasis on protecting
(Bioshield 2, continued on page 30)
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Sharp Increase in Heating Prices and Limited Gov-
ernment Assistance Spark Concerns about Potential
Home Heating Crisis
By Claire Mariano
While volatile energy prices have prompted the federal
government to increase its funding of the Low-Income Home
Energy Assistance Program, spending is still $2 billion below
the program's dicretionary limit and does not serve over 25
million poor households.
High energy prices and continued debate over
funding for the Low-Income Home Energy Assistance
Program ("LIHEAP")' has led to an outcry from
advocacy organizations, some elected officials and
others concerned with affordability of winter heating
bills for low-income families. The U.S. Department of
Energy's Energy Information Administration ("EIA")
estimates that households heating with natural gas will
spend, on average, $257 more in fuel costs this winter,
about a 35 percent increase from last winter.2 For
households using heating oil, the EIA estimates that
these households will average about $275, or 23
percent, more in heating costs when compared to last
winter.
Behind these market shifts, the EIA cites weak
natural gas production, decreased natural gas imports,
high natural gas demand and high oil prices.' In
addition, Aviva Aron-Dine, representative of the Center
for Budget and Policy Priorities, noted that "heating
costs have increased for a variety of reasons this year,
but the disruptions caused by Hurricanes Katrina and
Rita certainly have played a significant role."I
An Increased Energy Burden on Low-Income
Households
Advocates for low-income families and public
policy organizations argue for greater LIHEAP funding
by analyzing the heavy energy burden on low-income
households. 6 LIHEAP provides basic bill payment
assistance for heating and cooling costs, as well as
some funding for weatherization programs.' Despite
the dramatically increased energy costs, LIHEAP
funding is appropriated at essentially the same level
this year, and current projections mean that the low-
income households will likely pay the difference.'
According to Economic Opportunity Studies,
families in poverty will spend about 25 percent of their
Fiscal Year 2006 income on energy bills.9 There are
about 13 million such households in poverty, and there
are about 33 million people considered LIHEAP-
eligible. 0 For the LIHEAP eligible population, energy
bills will consume about 16 percent of their annual
income."' The burden on low-income households can
be contrasted with median-income households, whose
average income was just over $47,000 in 2005.12
Median-income households will need to spend more
than 5 percent of their annual income, after adjusting
income for inflation. 13
"Instability with the cost of energy (especially
natural gas) is most worrisome for low-income
families, whose tight budgets allow little flexibility in
spending," said John Colgan, Director of Public Policy
for the Illinois Community Action Association. "Winter
heating costs can easily push low-income households
into a cycle of increasing debt and/or service
disconnections."l4
(Energy Assistance, continued on page 23)
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The increasingly heavy burden of home energy
costs on low-income families is not being matched by
growing LIHEAP funds. The National Energy
Assistance Directors' Association ("NEADA")
released a study stating that the share of heating
expenditures covered by the average LIHEAP grant
is projected to decrease for homes heated by natural
gas from 68.6 percent to 28.8 percent.'5 The Center
on Budget and Policy Priorities stated that the
purchasing power of LIHEAP grants is lower than in
any year between 1982 and 2005.16
NEADA cited three factors to explain the
diminishing share of heating costs covered by LIIHEAP:
the price of heating costs has jumped significantly over
the past few years; the number of LIHEAP recipient
families was projected to increase by 33.1 percent,
while the federal funding has increased by only 20.1
percent, and the average grant assistance during this
period has declined from $319 to $288.17
In December 2005, NEADA released data
that showed that LIHEAP applications this winter were
already up an average of 10 percent, and some states
projected increased applications for heating assistance
of at least 25 percent.'" Mark Wolfe, Executive
Director of NEADA, stated that "three years ago,
energy was affordable for most households; today's
prices are not affordable for poor as well as lower
middle income families." 9
Recipients of LIHEAP Assistance
The LIHEAP statute sets certain income
eligibility guidelines for potential recipients of LIHEAP
funding.20 The maximum income for eligibility is 150
percent of the federal poverty level, except where 60
percent of the state median income is higher, and states
can set the limit as low as 110 percent of the federal
poverty level.2 ' Participation in the LIHEAP program
has increased by about 6 percent each year since
2002.22
According to the LIHEAP Home Energy
Notebook for Fiscal Year 2003, only 13 percent of
federally eligible households received LIHEAP benefits
in 2002.23 Because of such severe funding limitations,
the U.S. Department of Health and Human Services
has identified two main groups of households to target
for funding: vulnerable households, or households that
have at least one member who is a young child, an
individual with disabilities or an older adult; and high
burden households, which includes households with
the lowest incomes coupled with the highest home
energy costs.24
The government's goal of providing assistance
for only the neediest families was illustrated in a 2005
survey of 1,100 LIHEAP recipients conducted by the
National Energy Assistance Directors' Association
("NEADA"). 25 The NEADA found that 94 percent of
LIHEAP recipient households included at least one
member who was elderly, disabled, a child, or a single
adult supporting one or more children.26
Many of these households also had members
who suffered from medical or health-related problems.
Almost half of these households had a member who
suffered from asthma, emphysema, heart disease, or a
stroke.2 7 In fact, 32 percent of surveyed households
stated that they did not fill a prescription or took less
than the prescribed dosage because of energy bills in
the past five years. 28 This figure included 41 percent
of those with the described medical or health-related
problems. 29
In addition, a study by researchers from
Stanford University, the University of Chicago, the
RAND Corporation and UCLA for the National
Bureau of Economic Research found that low income
families may face greater nutritional problems during
periods of cold weather and high heating bills. 30 In
their study, the researchers stated that poor families
reduce their expenditure on food and have lower
caloric intake during the winter months. 3 1 The authors
estimated that a 10 degree decrease in temperature
resulted in about $11 reduction in monthly food
expenditures and a $37 increase in fuel expenditures
per month.32 These results were not found in wealthier
families, whose nutritional intakes did not significantly
change during the winter and summer months. 33
The authors argued that low-income families
are confronted with difficult choices when increasing
their expenditures on home energy, potentially at the
cost of reducing their spending on food and nutrition. 4
Further, they stated that their evidence "suggests that
poor parents are only imperfectly able to protect their
(Energy Assistance, continued on page 24)
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(Energy Assistance, continued from page 23)
children from the effect of cold weather shocks. Both
children and adults reduce their caloric intake during
winter months."35 In closing, they noted that "existing
social programs, taken together, are insufficient to
buffer poor families from cold weather shocks to family
budgets." 6 The National Bureau of Economic
Research study supports the view that home energy
assistance is not only about helping low-income
families with a basic necessity but is also a public health
issue.
"The struggle is going on because it is
about spending more money than ever
before when the federal government
has less money than ever before for all
domestic non-security programs."
-Dr. Meg Power, Senior Advisor for the
National Community Action Foundation
History and Funding of Low-Income
Home Energy Assistance Program
A number of public policy and advocacy
organizations for low-income households, such as
NEADA and the National Community Action
Foundation, have encouraged the federal government
to increase funding for LIHEAP.38 Using the U.S.
Department of Energy projections, the Center on
Budget and Policy Priorities stated that the cost to
heat homes for LIHEAP beneficiaries will increase
31.1 percent this winter.39
Congress authorized LIHEAP in a 1981
measure, and the program began in 1982.' LIHEAP
developed from several earlier energy programs that
were created following the 1970's energy crisis.4 1
LIHEAP funds are administered by the U.S.
Department of Health and Human Services, and are
allocated as block grants to states.4 2 LIHEAP funds
are also supplemented by funding from state
governments and non-profit organizations.4 3
In 1994, Congress amended the law to state
that the purpose of LIHEAP is "to assist low income
households, particularly those with the lowest income,
that pay a high proportion of household income for
home energy, primarily in meeting their immediate home
energy needs.""
In its Fiscal Year 2003 LIHEAP Report to
Congress, the U.S. Department of Health and Human
Services-Administration for Children and Families
stated that approximately 5 million households received
LIHEAP assistance, including both heating and cooling
costs. 45
Congress appropriates funding for LIHEAP
annually, and the amount has fluctuated over the years."
Congress appropriated about $2.1 billion in 1985 for
LIHEAP, and just $1 billion in 1997.' About $2.183
billion was appropriated in 2005 to assist roughly 4.9
million low-income households.4 8
In July of 2005, Congress passed the Energy
Policy Act, which authorized $5.1 billion in funding for
LIHEAP for each of the years from 2005 through
2007.49 Though the measure was signed into law by
President Bush in August of 2005, Congress still has
discretion to appropriate less funding for the program,
and so far has not appropriated anywhere near the
$5.1 billion amount.o Congress only approved $2.161
billion in LIHEAP funding for this winter, and President
Bush released about $100 million in LIHEAP
emergency contingency funds on January 5, 2006.1'
Government Response to LIHEAP Funding
Problem
In addition to a public outcry from organizations
like NEADA, the National Consumer Law Center, the
Campaign for Home Energy Assistance and others,
many government officials have reacted to the
impending need.
"The struggle is going on because it is about
spending more money than ever before when the federal
government has less money (relative to size) than ever
before for all domestic non-security programs," said
Dr. Meg Power, Senior Advisor for the National
Community Action Foundation.52
"People who want to spend on other things or not spend
on the poor are delaying in hopes of an early spring
and the return of the nation's customary attention deficit
on poverty."5 3
(Energy Assistance, continued on page 25)
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A group of U.S. Senators has requested that
the Bush Administration allocate another $2.92 billion
in funding for LIHEAP and winter heating programs
for this year.5 4 The legislators argue that low-income
families this winter have faced choices of whether to
heat their home or buy basic home necessities, like
food or prescription drugs, which is a choice they
shouldn't have to make." In March, 2006, President
Bush signed a measure allocating $1 billion in additional
LIHEAP funding for states.5 6 The law brings this
winter's funding total to $3.16 billion.5 7
Senator Olympia Snowe (R-Maine), a
sponsor of the legislation, stated that "[w]ith the
President's signature, relief will soon be on the way to
families struggling to heat their home amidst record-
high fuel prices.""
State governments have also stepped in to
assist low-income families. In Illinois, the Governor's
Special Director for Emergency Energy Assistance
worked with the state's major utilities companies, who
agreed to waive the reconnection fees and suspend
deposits for customers receiving LIHEAP benefits.5 9
In addition, the utilities agreed not to disconnect
residential heating customers for non-payment between
December 1, 2005 and March 31, 2006.60 Called
"Keep Warm Illinois," the governor's office also held
a number of WinterAssistance Days to offer information
about available benefits. 61
As energy prices continue to increase, home
energy costs for low-income families will be an ongoing
and important public health and policy issue.
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